Healthcare Industry News:  Exactech 

Devices Orthopaedic

 News Release - July 20, 2006

Exactech Adds Cemented Stem to Novation(TM) Hip System

GAINESVILLE, Fla., July 20 (HSMN NewsFeed) -- Exactech (Nasdaq: EXAC ), a producer and distributor of bone and joint restoration products including orthopaedic implants and biologic materials, announced today that it has added a cemented stem to its Novation(TM) Hip System.

Exactech Executive Vice President of Research and Development Gary Miller, Ph.D., said, "This represents an important expansion of the company's latest hip prosthesis line. The clinically proven Novation cemented stem is based on clinically proven technologies for joint reconstruction. Historically, cemented stems have been a common preference among orthopaedic surgeons and are often selected for patients whose bone is not suitable for press-fit applications. Now, with one integrated set of surgical instrumentation, the Novation system provides various styles of press-fit and cemented implants to allow surgeons the intra-operative flexibility of matching the implant geometry, materials and style to the patients' needs."

Exactech CFO Jody Phillips said, "This addition provides a broad platform of femoral stems in our Novation product line, which will act as the foundation for Connexion(TM) GXL, our enhanced polyethylene and the alternative bearing systems that we have planned, which will include hard- bearing surfaces."

The domestic primary hip arthroplasty market involves more than 400,000 procedures per year.

About Exactech

Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech's orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States and in more than 25 countries in Europe, Asia, Australia and Latin America. Copies of Exactech's press releases, SEC filings, current price quotes and other valuable information for investors may be found at and .

An investment profile on Exactech may be found at .

Questions should be directed to Frank Hawkins or Julie Marshall of Hawk Associates, Inc. at (305) 451-1888, e-mail: .

This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company's expectations or beliefs concerning future events of the company's financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward- looking statements. These factors include the effect of competitive pricing, the company's dependence on the ability of third-party manufacturers to produce components on a basis that is cost-effective to the company, market acceptance of the company's products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.

Source: Exactech

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.